首页> 外文期刊>The Canadian journal of hospital pharmacy. >Stability of Hydromorphone-Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use
【24h】

Stability of Hydromorphone-Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use

机译:儿科用玻璃瓶,塑料注射器和静脉输液袋中氢吗啡酮-氯胺酮溶液的稳定性

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To evaluate the stability of mixtures of hydromorphone and ketamine in 0.9% sodium chloride (normal saline [NS]) after storage for up to 7 days at room temperature (25degC).Methods: The stability of 3 standard mixtures of hydromorphone and ketamine (hydromorphone 0.2 mg/mL + ketamine 0.2 mg/mL, hydromorphone 0.2 mg/mL + ketamine 0.6 mg/mL, and hydromorphone 0.2 mg/mL + ketamine 1.0 mg/mL) in NS was studied. Portions of each mixture were transferred to 3 brown glass bottles (100 mL), 3 plastic syringes (50 mL), and 3 IV bags (50 mL), which were then stored at room temperature (25degC). Physical characteristics, including pH, colour, and precipitation, were evaluated daily. Three 1.5-mL samples were collected from each bottle, syringe, and IV bag at baseline, at 24, 48, and 72 hours, and on day 7. Samples were analyzed in triplicate by a stability-indicating high-performance liquid chromatography method. Solutions were considered stable if they maintained 90% of the initial concentration of each drug. Samples from syringes and IV bags were subjected to standard sterility testing by incubation for 5 days in an enriched culture media.Results: No notable changes in pH or colour were observed, and no precipitation occurred in any of the solutions. All formulations maintained more than 90% of the initial concentration of each drug on day 7. No bacterial growth was observed in any of the samples tested.Conclusions: Mixtures of hydromorphone and ketamine were stable for up 7 days at 25degC, and the sterility of the preparations was maintained. Because stability alone does not guarantee efficacy, it is recommended that clinical studies be conducted to evaluate the pharmacokinetics and pharmacodynamics of these formulations.
机译:目的:评估氢吗啡酮和氯胺酮混合物在室温(25℃)下保存长达7天后在0.9%氯化钠(生理盐水[NS])中的稳定性。方法:三种氢吗啡酮和氯胺酮标准混合物的稳定性研究了NS中的氢吗啡酮0.2 mg / mL +氯胺酮0.2 mg / mL,氢吗啡酮0.2 mg / mL +氯胺酮0.6 mg / mL和氢吗啡酮0.2 mg / mL +氯胺酮1.0 mg / mL)。将每种混合物的一部分转移到3个棕色玻璃瓶(100 mL),3个塑料注射器(50 mL)和3个IV袋(50 mL)中,然后将其在室温(25℃)下保存。每天评估物理特性,包括pH值,颜色和沉淀。在基线,第24、48和72小时以及第7天,分别从每个瓶,注射器和IV袋中收集了三个1.5 mL样品,并通过指示稳定性的高效液相色谱法一式三份分析样品。如果溶液保持每种药物初始浓度的90%,则认为溶液是稳定的。在富营养培养基中孵育5天,对注射器和静脉输液袋的样品进行标准无菌测试。结果:未观察到pH或颜色的显着变化,任何溶液均未发生沉淀。在第7天,所有制剂的每种药物的初始浓度都保持在90%以上。结论:氢吗啡酮和氯胺酮的混合物在25℃下可稳定7天,并且无菌。保持准备。由于仅靠稳定性不能保证疗效,因此建议进行临床研究以评估这些制剂的药代动力学和药效学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号